INO250110C3500
- 0.05
- 0.000.00%
Inovio Pharmaceuticals Newsroom
Why Inovio Pharmaceuticals (INO) Stock Is Skyrocketing
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Top 3 Health Care Stocks That Could Blast Off This Month
Catalyst Watch: Eyes on Electric Vehicle Deliveries, Retail Data and Housing Reads
Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet
Top Midday Decliners
Inovio Pharmaceuticals Shares Touch 52-Week Low After $30M Offering
Crude Oil Gains Over 1%; RH Shares Jump On Strong Forecast
US Stocks Mixed; Broadcom Shares Surge On Upbeat Earnings
Why Inovio Pharmaceuticals (INO) Stock Is Down 40%
Wall Street Set to Open Higher Friday as Investors Shake Off Bad Week
Investors Look to End Week on Strong Note as US Futures Rise in Friday's Premarket
Inovio Pharmaceuticals Priced An Underwritten Public Offering Of 10M Shares And Accompanying Warrants To Purchase 10M Shares At An Exercise Price Of $3.76/Share, At A Combined Public Offering Price Of $3/Share And Accompanying Warrant, With Gross...
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
RH, Broadcom And 3 Stocks To Watch Heading Into Friday
Inovio Down 20% After Hours on Planned Stock and Warrant Sale
Express News | Inovio Announces Proposed Public Offering